Iron deficiency anemia in infants aged 12-15 months in Ahwaz, Iran

Seyed Mehdi Monajemzadeh1, Mohammad Reza Zarkesh

  • 1Pediatric Unit, Golestan Hospital, Jondishapour University of Medical Sciences, Ahwaz, Iran. monajemzadehmd@yahoo.com

Insights

Iron deficiency anemia (IDA) is prevalent in Iranian infants. Early iron supplementation and exclusive breastfeeding are crucial for preventing iron deficiency (ID) and IDA in this vulnerable population.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Public Health

Background:

  • Iron deficiency anemia (IDA) is a global nutritional challenge, particularly affecting infants aged 4-24 months in developing nations.
  • Infants aged 12-15 months in Ahwaz, Iran, represent a high-risk group for iron deficiency (ID) and IDA.

Purpose of the Study:

  • To determine the prevalence of ID and IDA in infants aged 12-15 months in Ahwaz, Iran.
  • To identify risk factors associated with ID and IDA in this population.

Main Methods:

  • A cross-sectional study involving 126 infants aged 12-15 months in Ahwaz, Iran.
  • Measurement of hemoglobin (Hb), serum ferritin, hematocrit, and mean corpuscular volume.
  • Definition of anemia as Hb < 11 g/dL and ID as ferritin < 12 microg/mL.

Main Results:

  • The prevalence of ID was 31.7% and IDA was 26.2% among the studied infants.
  • Infants fed cow's milk and those not receiving ferrous sulfate supplementation showed a higher tendency towards IDA.

Conclusions:

  • ID and IDA are common health issues in 12-15-month-old infants in Ahwaz, Iran.
  • Recommendations include promoting exclusive breastfeeding up to 4-6 months and ensuring iron supplementation for at-risk infants.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...